Anti-VEGF Therapy Versus Dexamethasone Implant for DME

NCT03999125 · clinicaltrials.gov ↗

PHASE4

Phase

UNKNOWN

Status

150

Enrollment

OTHER

Sponsor class

Conditions

Clinically Significant Macular Edema Due to Diabetes Mellitus

Interventions

DRUG: Aflibercept,
DRUG: Ranibizumab Injection
DRUG: Ozurdex Drug Implant Product

Sponsor

Sudhalkar Eye Hospital